Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 51.61 - -
Change - -45.55% -68.19% 94.7% -53.94% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 51.61 51.61 51.61
Change - -45.55% -68.19% 94.7% -53.94% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 43x 39.7x 32.3x
EV / Revenue - 0x 0x 0x 43x 39.7x 32.3x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -7.94x -8.06x -
EV / FCF - -0x - -0x -8.06x -14.3x -13.2x
FCF Yield - -9.52% - -4.08% -12.4% -6.98% -7.56%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.6450 0.6450 0.6450
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 3/1/23 5/15/24 5/13/25 5/13/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
62.93x5.1x18.96x2.75% 305B
23.73x3.26x11.62x1.67% 69.67B
11.36x5.76x8.87x - 8.99B
17.15x2.18x7.47x2.61% 8.52B
35.9x6.78x19.38x - 4.17B
20.86x5.9x16.68x-.--% 4.11B
38.59x2.18x26.89x0.8% 3.48B
107.26x - - -.--% 2.77B
Average 39.72x 4.45x 15.69x 1.3% 50.88B
Weighted average by Cap. 53.51x 4.74x 17.28x 2.49%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA